Skip to main content
Premium Trial:

Request an Annual Quote

William Haseltine, Donald Segal, Jerome McElroy, David Palmer, Reed McManigle, Pamela Bush, Grainne McClorey

Premium

William Haseltine will retire as chairman and CEO of Human Genome Sciences, the company said. He intends to step down once a new CEO has been appointed.


Donald Segal has been appointed president and CEO of Aurora, Canada-based Helix BioPharma. He has been executive vice president of Helix since 1995. Segal replaces Jerome McElroy as president. McElroy will remain chairman of the board.


The Pittsburgh Life Sciences Greenhouse has promoted four new staffers to become members of its management team. David Palmer has become chief operating officer for PLSG. He was previously vice president of business development for PLSG. Prior to that, he was CEO of Confirmant. He holds a master’s in public management from Carnegie Mellon University and a bachelor’s from West Virginia University.

Reed McManigle has become director of investment programs and incubation services at PLSG. He was previously director of incubator and entrepreneurial services. Prior to that, he was technology licensing manager at the University of Pittsburgh. He holds an MBA from Carnegie Mellon, a law degree from the University of Pennsylvania, and a BA from the University of Dayton.

Pamela Bush has become investment program manager at PLSG. She was previously program associate. Before that, she was a consultant for LaunchCyte. She has a doctorate in biological sciences from Carnegie Mellon and a bachelor’s in biology from Florida International University.

Grainne McClorey has become executive assistant. She was previously in general administration.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.